In this study we want to validate a risk score for chronic dizziness with persistent impairment in older dizzy patients in general practice. Furthermore, we want to investigate the effectiveness of a risk factor-guided, i.e. a prognosis-oriented,…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Duizeligheid
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary clinical outcome is dizziness related impairment at follow-up,
which will be assessed using the Dizziness Handicap Inventory (DHI).
Secondary outcome
Secondary outcomes are quality of life (EQ-5D-5L), difference in *Fall Risk
Increasing Drug* count, anxiety/depression, dizziness frequency, fall
frequency, health care utilization.
Background summary
When treating older patients with dizziness in primary care, the current
diagnosis oriented approach is insufficient. Often, it is not possible to
diagnose an underlying disease and even if a disease is diagnosed, therapeutic
options are often limited. In this study a prognosis oriented approach for
dizziness in older people in primary care will be investigated.
Study objective
In this study we want to validate a risk score for chronic dizziness with
persistent impairment in older dizzy patients in general practice. Furthermore,
we want to investigate the effectiveness of a risk factor-guided, i.e. a
prognosis-oriented, intervention for dizzy older patients with a high risk of
persistent impairment.
Study design
The study protocol consists of two parts. Firstly, we will perform a validation
study to externally validate a 7-item risk score for chronic dizziness with
persistent impairment. Secondly, we will perform an intervention study, using a
cluster controlled clinical trial. In the intervention study we will compare
the effectiveness of a targeted intervention for dizzy older patients with a
high risk of persistent impairment with usual care during one year of
follow-up.
Intervention
In older patients with a high risk of persistent impairment because of
dizziness we will compare a risk factor-guided intervention consisting of one,
two, or three of the following interventions: (1) medication adjustment in case
of the usage of >= 3 Fall Risk Increasing Drugs (FRIDs), (2) stepped care in
case of anxiety/depression, and (3) exercise therapy in case of impaired
functional mobility. All three interventions are evidence based and usual care
for the above-mentioned risk factors.
Study burden and risks
A group of 125 patients of the validation group will receive 3 questionnaires
by mail at baseline and at 6 and 12 months follow-up. The group of 250 patients
participating in the intervention study will receive four questionnaires at
baseline, 3, 6 and 12 months follow-up, and will keep up a diary to report
dizziness frequency and fall frequency. Filling out the questionnaires will
take about 30 minutes each time. Keeping up the diary will take 1 minute every
week.
All 375 patients will be subjected to a baseline assessment of 30 minutes at
their home including a structured interview and a simple test to determine the
functional mobility of the patient.
Patients in the intervention group (n=125) will receive - in addition to usual
(general practice) care - a targeted intervention, depending on the presence of
specific risk-factors. Participating in the intervention 'medication adjustment
' will ask one additional visit to the patients' GP to discuss the outcomes of
the medication evaluation. Time investment for the patient when participating
in the stepped-care program depends on the severity of the anxiety/depression:
the more severe the complaints of the patient, the more time the stepped-care
program will cost. We expect an average time investment of of 4 hours per
patients in the stepped-care program. The exercise program takes 2 sessions of
50 minutes every week for 8 weeks.
Patients in the control group (n=125) and validation group (n=125) will receive
(general practice) care as usual. No treatment will be denied to any
participants nor will it be postponed. There are no major medical health risks
for participants in this study. The experimental group may benefit from the
intervention by a reduction of impairment due to dizziness and/or a decrease
in dizziness frequency.
De Boelelaan 1117
Amsterdam 1081 HZ
NL
De Boelelaan 1117
Amsterdam 1081 HZ
NL
Listed location countries
Age
Inclusion criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- being 65 years or older
- consulted a general practitioner for a new episode of dizziness, defined as recurrent dizziness for at least one month, including a giddy or rotational sensation, loss of balance, faint feeling, light-headedness, instability, or tendency to fall
- current dizziness-related impairment (Dizziness Handicap Inventory score >= 30)
- ability to speak, read and write Dutch
Exclusion criteria
- severe cognitive impairment according to the patient*s GP
- serious co morbidity that precludes participation in an exercise program
- current enrolment in interfering study
- if the patient*s GP deems participation of the patient in this study undesirable and/or if participation could damage the doctor-patient relationship for any reason. The GP*s judgement in relation to possible damage of the doctor-patient relationship will always overrule other in- or exclusion criteria.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL49604.029.14 |